Sodium Deoxycholate (CAS: 302-95-4) is the sodium salt form of endogenous bile acid deoxycholic acid.As a secondary bile acid (20-30% of intestinal bile acids), it is generated via 7α-dehydroxylation of primary bile acids by gut microbiota. Approved by the FDA as a solubilizer for injectable lipophilic drugs (21 CFR 210.3), it is widely used in cell biology (e.g., membrane protein extraction). EMA listed it in the Inactive Ingredients Database (IID) in 2021.
Product Name: Sodium Deoxycholate
IUPAC Name: Sodium (3α,5β,12α)-3,12-dihydroxy-24-oxocholan-24-olate
CAS No.: 302-95-4